Chronic Graft Versus Host Disease  >>  cyclosporine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00031824: Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease

Completed
3
82
US, Canada, Europe, RoW
cyclosporine, hydroxychloroquine, prednisone, tacrolimus
Children's Oncology Group, National Cancer Institute (NCI)
Graft Versus Host Disease
05/05
01/11
NCT00298324 / 2005-006178-86: Myfortic - Treatment for Extensive cGvHD

Terminated
3
34
Europe, RoW
Myfortic, Prednisone and Cyclosporine
European Society for Blood and Marrow Transplantation, Novartis
Graft vs Host Disease
11/09
11/10

Download Options